WELCOME TO THE ADD-ASPIRIN WEBSITE

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.           

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:
1. Worcestershire Royal Hospital
2. University Hospitals Coventry & Warwickshire
3. Royal Marsden Hospitals
4. Bristol Haematology & Oncology Centre
5. Churchill Hospital, Oxford


*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR
FAQs*

NEWS

18th April 2017

The Add-Aspirin office is closed due to a major power-cut. The trial team are working remotely and have no access to phone or faxes. Please send all queries to mrcctu.add-aspirin@ucl.ac.uk, and we will answer as soon as possible.

Please also send any SAE forms to us via email, and we will confirm receipt.

Site access to all other systems is working as usual, including access to the registration server, DSMS and the randomisation phone line.

Apologies for the inconvenience and thank you for your patience.

24th March 2017

Substantial Amendment:
Protocol v5.0 Launch


Please make sure to submit the amendment documentation to mrcctu.add-aspirin@ucl.ac.uk. by 28th April 2017.

Quick links for
NHS professionals


REGISTER A PARTICIPANT

To RANDOMISE a participant please call +44 (0)20 7670 4777

UNBLIND A PARTICIPANT

 

BREAST


We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here   

Top recruiters: Royal Marsden Hospitals, Worcestershire Royal Hospital, Addenbrookes, Churchill Hospital Oxford

PARTICIPANTS REGISTERED: 1273
PARTICIPANTS RANDOMISED: 933   

COLON/RECTUM 


We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, Worcestershire Royal Hospital, St James 's University Hospital

PARTICIPANTS REGISTERED: 675
PARTICIPANTS RANDOMISED: 506

STOMACH/OESOPHAGUS 


We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: Leicester Royal Infirmary, The Christie, Manor Hospital

PARTICIPANTS REGISTERED: 80
PARTICIPANTS RANDOMISED: 55

PROSTATE


We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here    

Top recruiters: Bristol Haematology & Oncology Centre, UCHW, University Hospital of Wales
                                             PARTICIPANTS REGISTERED: 529
PARTICIPANTS RANDOMISED: 394
     

The trial is being jointly funded by Cancer Research UK (grant number C471 /A15015, www.cancerresearchuk.org), the National Institute for Health Research Health Technology Assessment Programme (project number 12/01/38, www.nihr.ac.uk) and the MRC Clinical Trials Unit at UCL.
© Add-Aspirin, MRC CTU at UCL cookies